Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study

Background: Test-trace-isolate programs are an essential part of COVID-19 control that offer a more targeted approach than many other non-pharmaceutical interventions. Effective use of such programs requires methods to estimate their current and anticipated impact. Methods and Findings: We present a mathematical modeling framework to evaluate the expected reductions in the reproductive number, R, from test-trace-isolate programs. This framework is implemented in a publicly available R package and an online application. We evaluated the effects of case detection, speed of isolation, contact tracing completeness and speed of quarantine using parameters consistent with COVID-19 transmission (R0=2.5, generation time 6.5 days). We show that R is most sensitive to changes to the proportion of infections detected in almost all scenarios, and other metrics have a reduced impact when case detection levels are low (<30%). Although test-trace-isolate programs can contribute substantially to reducing R, exceptional performance across all metrics is needed to bring R below one through test-trace-isolate alone, highlighting the need for comprehensive control strategies. Formally framing the dynamical process also indicates that metrics used to evaluate performance of test-trace-isolate, such as the proportion of identified infections among traced contacts, may be misleading. While estimates of program performance are sensitive to assumptions about COVID-19 natural history, our qualitative findings are robust across numerous sensitivity analyses. Conclusions: Effective test-trace-isolate programs first need to be strong in the "test" component, as case detection underlies all other program activities. Even moderately effective test-trace-isolate programs are an important tool for controlling the COVID-19 pandemic, and can alleviate the need for more restrictive social distancing measures.

[1]  Policy brief: The impact of COVID-19 on children , 2020 .

[2]  Georgia Salanti,et al.  The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis , 2020, medRxiv.

[3]  Daniel Eichner,et al.  Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020. , 2020, JAMA.

[4]  P. E. Kopp,et al.  Superspreading and the effect of individual variation on disease emergence , 2005, Nature.

[5]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[6]  P. Klepac,et al.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts , 2020, The Lancet Global Health.

[7]  Edward H. Kaplan,et al.  Logistics of Aggressive Community Screening for Coronavirus 2019. , 2020, JAMA health forum.

[8]  Sam Abbott,et al.  Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts , 2020, Wellcome Open Research.

[9]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[10]  Sebastian Funk,et al.  Extended data: Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China , 2020 .

[11]  A. Wagstaff,et al.  A Cluster Randomized Trial , 2014 .

[12]  A. Flahault,et al.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.

[13]  H. Tian,et al.  Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China , 2020, BMJ Global Health.

[14]  C. Fraser,et al.  Factors that make an infectious disease outbreak controllable. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Hernán,et al.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.

[16]  Sarah V Leavitt,et al.  HIT-COVID, a global database tracking public health interventions to COVID-19 , 2020, Scientific data.

[17]  Tangchun Wu,et al.  Reconstruction of the full transmission dynamics of COVID-19 in Wuhan , 2020, Nature.

[18]  R. Morgan,et al.  COVID-19: the gendered impacts of the outbreak , 2020, The Lancet.

[19]  Márcia R. Ferreira,et al.  A structured open dataset of government interventions in response to COVID-19 , 2020, Scientific Data.

[20]  B. Giraudeau [The cluster-randomized trial]. , 2004, Medecine sciences : M/S.

[21]  S. Bhatt,et al.  Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study , 2020, The Lancet Global Health.

[22]  Young Joon Park,et al.  Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020 , 2020, Emerging infectious diseases.

[23]  Sebastian Funk,et al.  Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks , 2020, medRxiv.

[24]  Ganna Rozhnova,et al.  Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study , 2020, The Lancet Public Health.

[25]  Joel Hellewell,et al.  Using a real-world network to model localized COVID-19 control strategies , 2020, Nature Medicine.

[26]  Sebastian Funk,et al.  Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks. , 2020, Wellcome open research.

[27]  Benjamin J. Cowling,et al.  Respiratory virus shedding in exhaled breath and efficacy of face masks , 2020, Nature Medicine.

[28]  H. Oshitani Cluster-based approach to Coronavirus Disease 2019 (COVID-19) response in Japan-February-April 2020. , 2020, Japanese journal of infectious diseases.

[29]  Milind Tambe,et al.  Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance , 2020, medRxiv : the preprint server for health sciences.